Antihypertensive Drugs and Coronary Artery Disease: Evidence from Controlled Trials

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.12, Iss.3, 2005-01, pp. : 119-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence against hypercoagulability in coronary artery disease

By Gorog P. Ridler C.D. Rees G.M. Kovacs I.B.

Thrombosis Research, Vol. 79, Iss. 4, 1995-08 ,pp. : 377-385

Elsevier

Access to resources Recommend Favorite

Primary Prevention of Sudden Cardiac Death: Trials in Patients with Coronary Artery Disease

By Buxton A.E. Ellison K.E. Kirk M.M. Frain B. Koo C. Gandhi G. Khouzam S.

Journal of Interventional Cardiac Electrophysiology, Vol. 9, Iss. 2, 2003-10 ,pp. : 203-206

Springer Publishing Company

Access to resources Recommend Favorite

Evidence of reduced coronary artery disease risk for apolipoprotein 2/3 heterozygotes

By Mamotte C.D.S. Burke V. Taylor R.R. van Bockxmeer F.M.

European Journal of Internal Medicine, Vol. 13, Iss. 4, 2002-06 ,pp. : 250-255

Elsevier

Access to resources Recommend Favorite

Endothelin in coronary artery disease

By Pernow John

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 5, 2004-10 ,pp. : 257-258

Informa Healthcare

Access to resources Recommend Favorite

Vectorelectrocardiography in Coronary Artery Disease

By Dellborg Mikael

Scandinavian Cardiovascular Journal, Vol. 35, Iss. 2, 2001-03 ,pp. : 72-74

Informa Healthcare

Access to resources Recommend Favorite